István Láng
Impact in
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 90
- Cancer Treatment and Pharmacology 43
- HER2/EGFR in Cancer Research 32
- Colorectal Cancer Treatments and Studies 24
-
- Advanced Breast Cancer Therapies 29
- Lung Cancer Treatments and Mutations 7
- Gastric Cancer Management and Outcomes 6
- Co-authors
- Richard D. Gelber (24 shared papers)David Cunningham (5 shared papers)Eric Van Cutsem (5 shared papers)Philippe Rougier (2 shared papers)Gunnar Folprecht (2 shared papers)Claus-Henning Köhne (2 shared papers)Marek P. Nowacki (1 shared paper)Fortunato Ciardiello (1 shared paper)
- Journals
- Journal of Clinical Oncology (29 papers)Cancer Research (14 papers)Annals of Oncology (11 papers)The Lancet Oncology (6 papers)Pathology & Oncology Research (4 papers)
- Partner nations
- HungaryUnited StatesSwitzerland
In The Last Decade
István Láng
110 papers receiving 6.8k citations
István Láng's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 5.2k
- Cancer Research 2.0k
- Hepatology 605
- Pulmonary and Respiratory Medicine 2.3k
- Pathology and Forensic Medicine 999
Countries citing papers authored by István Láng
This map shows the geographic impact of István Láng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Láng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Láng more than expected).
Fields of papers citing papers by István Láng
This network shows the impact of papers produced by István Láng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Láng. The network helps show where István Láng may publish in the future.
Co-authors
The 25 scholars most cited alongside István Láng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status Hit paper breakdown → | 2011 | 1441 |
| 2 | Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer Hit paper breakdown → | 2017 | 918 |
| 3 | Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 Hit paper breakdown → | 2007 | 693 |
| 4 | Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial Hit paper breakdown → | 2013 | 438 |
| 5 | Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial Hit paper breakdown → | 2010 | 425 |
| 6 | 2016 | 166 | |
| 7 | 1986 | 161 | |
| 8 | 2013 | 142 | |
| 9 | 2014 | 134 | |
| 10 | 2009 | 133 | |
| 11 | 2007 | 127 | |
| 12 | 2013 | 119 | |
| 13 | 2010 | 117 | |
| 14 | 2008 | 111 | |
| 15 | 2007 | 106 | |
| 16 | 2012 | 102 | |
| 17 | 2012 | 102 | |
| 18 | 2014 | 100 | |
| 19 | 2008 | 98 | |
| 20 | 2016 | 90 |
About István Láng
István Láng is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 113 papers that have together received 7.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (43 papers), Breast Cancer Treatment Studies (38 papers), HER2/EGFR in Cancer Research (32 papers), Advanced Breast Cancer Therapies (29 papers), Colorectal Cancer Treatments and Studies (24 papers), Estrogen and related hormone effects (14 papers), Lung Cancer Treatments and Mutations (7 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (5.2k citations), Cancer Research (2.0k citations), Hepatology (605 citations), Pulmonary and Respiratory Medicine (2.3k citations) and Pathology and Forensic Medicine (999 citations). István Láng has collaborated with scholars based in Hungary, United States and Switzerland. Frequent co-authors include Richard D. Gelber, David Cunningham, Eric Van Cutsem, Philippe Rougier, Gunnar Folprecht, Claus-Henning Köhne, Marek P. Nowacki, Fortunato Ciardiello, Angela Zubel and Joan Maurel. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, The Lancet Oncology and Pathology & Oncology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.